Medical decision in COPD: the evidence-based history

Autores/as

  • António Duarte-de-Araújo 1. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 2. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal. 3. Respiratory Department, H. Sª Oliveira, Guimarães, Portugal. http://orcid.org/0000-0001-5811-3786
  • Miguel Guimarães Respiratory Department, Centro Hospitalar de Gaia/Espinho
  • Pedro Teixeira 1. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 2. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Venceslau Hespanhol 1.Respiratory Department, Centro Hospitalar de S. João, Porto, Portugal. 2. Faculty of Medicine (FMUP), University of Porto, Portugal.
  • Jaime Correia-de-Sousa 1. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 2. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal.

DOI:

https://doi.org/10.32385/rpmgf.v37i3.12780

Palabras clave:

COPD, Evidence, Randomized controlled trials, Treatment, Outcomes

Resumen

Randomized controlled trials together with systematic reviews and meta-analyses have been the cornerstone of clinical research. Some studies, because of the size of the sample, the use of randomization and well-defined measurements, the participation of multiple institutions, or long-term follow-up, are able to give a significant level of evidence. We chronologically describe and comment on a group of trials on chronic obstructive pulmonary disease (COPD) that have significantly influenced the scientific and medical community in understanding and managing the disease in the first years of the XXI century. They contributed to the different versions of the GOLD strategy.

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

  • António Duarte-de-Araújo, 1. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 2. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal. 3. Respiratory Department, H. Sª Oliveira, Guimarães, Portugal.

    Pneumologista do hospital de Guimarães.

    Doutorando em medicina.

  • Miguel Guimarães, Respiratory Department, Centro Hospitalar de Gaia/Espinho
    Pneumologista do hospital de Gaia-Espinho
  • Pedro Teixeira, 1. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 2. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
    Docente da Escola de Medicina, Universidade do Minho
  • Venceslau Hespanhol, 1.Respiratory Department, Centro Hospitalar de S. João, Porto, Portugal. 2. Faculty of Medicine (FMUP), University of Porto, Portugal.
    Diretor de serviço de pneumologia do hospital de S. João e Professor de pneumologia da faculdade de Medicina da Universidade do Porto
  • Jaime Correia-de-Sousa, 1. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. 2. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal.

    Medico Especialista de Medicina Geral e Familiar.

    Docente da Escola de Medicina da Universidade do Minho

Descargas

Publicado

2021-07-02

Número

Vol. 37 Núm. 3 (2021): Revista Portuguesa de Medicina Geral e Familiar

Sección

Opinião e Debate

Licencia

Los autores otorgan a RPMGF el derecho exclusivo de publicar y distribuir en medios físicos, electrónicos, de radiodifusión u otros medios que pueda existir el contenido del manuscrito identificado en esta declaración. También otorgan a RPMGF el derecho de usar y explorar el presente manuscrito, es decir, de ceder, vender o licenciar su contenido. Esta autorización es permanente y entra en vigor desde el momento en que se envía el manuscrito, tiene la duración máxima permitida por la legislación portuguesa o internacional aplicable y tiene un alcance mundial. Los autores declaran además que esta transferencia se realiza de forma gratuita. Si la RPMGF informa a los autores que ha decidido no publicar su manuscrito, la cesión exclusiva de derechos cesa inmediatamente.

Los autores autorizan a RPMGF (oa una entidad que éste designe) a actuar en su nombre cuando considere que existe una infracción a los derechos de autor.

Cómo citar

Medical decision in COPD: the evidence-based history. (2021). Revista Portuguesa De Medicina Geral E Familiar, 37(3), 272-6. https://doi.org/10.32385/rpmgf.v37i3.12780